Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan-Feb;77(1):52-8.
doi: 10.18043/ncm.77.1.52.

Enrollment and Racial Disparities in Cancer Treatment Clinical Trials in North Carolina

Leah L Zullig  1 , Alice G Fortune-Britt  2 , Shangbang Rao  3 , Seth D Tyree  4 , Paul A Godley  5 , William R Carpenter  6
Affiliations

Enrollment and Racial Disparities in Cancer Treatment Clinical Trials in North Carolina

Leah L Zullig et al. N C Med J. 2016 Jan-Feb.

Abstract

Background: Clinical trials provide access to innovative, high-quality cancer treatment. Simultaneously, broad access helps to ensure that trials include heterogeneous patient populations, which improves the generalizability of findings and the development of interventions that are effective for diverse populations. We provide updated data describing enrollment into cancer treatment trials in North Carolina.

Methods: For the period 1996-2009, person-level data regarding cancer clinical trial enrollment and cancer incidence were obtained from the North Carolina Central Cancer Registry and the National Cancer Institute (NCI). Enrollment rates were estimated as the ratio of trial enrollment to cancer incidence for race, sex, and year for each county, Area Health Education Center region, and the state overall. Enrollment rates for common cancers are presented.

Results: From 1996 to 2009, North Carolina NCI treatment trial enrollment rates were 2.4% and 2.2% for white patients and minority patients, respectively. From 2007 to 2009, rates were 3.8% for white women, 3.5% for minority women, 1.3% for white men, and 1.0% for minority men; there was greater enrollment among more urban populations (2.4%) than among the most rural populations (1.5%).

Limitations: This study is limited to NCI-sponsored treatment trials in North Carolina. Policies governing collection of original data necessitate a delay in data availability.

Conclusions: Effort is needed to ensure trial access and enrollment among all North Carolina populations. Specifically, we identified racial and sex disparities, particularly for certain cancers (eg, breast cancer). Programs in North Carolina and across the nation can use the methods we employed to assess their success in broadening clinical trial enrollment to include diverse populations.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Trends in NCI treatment trial enrollment rates in North Carolina, by race, 3-year averages, 1996–2009.
Figure 2
Figure 2
Trends in NCI treatment trial enrollment rates in North Carolina, by gender and race, 3-year averages, 1996–2009.
Figure 3
Figure 3
Trends in NCI treatment trial enrollment rates in North Carolina, by type of cancer, 3-year averages, 1996–2009.
Figure 4
Figure 4
Enrollment in NCI Cancer Treatment Clinical Trials, by Area Health Education Center region, 2007-2009.
See this image and copyright information in PMC

References

    1. Minasian LM, Carpenter WR, Weiner BJ, Anderson DE, McCaskill-Stevens W, Nelson S, Whitman C, Kelaghan J, O'Mara AM, Kaluzny AD. Translating research into evidence-based practice: the National Cancer Institute Community Clinical Oncology Program. Cancer. 2010;116(19):4440–4449. - PMC - PubMed
    1. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA : the journal of the American Medical Association. 2004;291(22):2720–2726. - PubMed
    1. Carpenter WR, Tyree S, Wu Y, Meyer AM, DiMartino L, Zullig L, Godley PA. A surveillance system for monitoring, public reporting, and improving minority access to cancer clinical trials. Clinical trials (London, England) 2012;9(4):426–435. - PMC - PubMed
    1. Clauser SB, Johnson MR, O'Brien DM, Beveridge JM, Fennell ML, Kaluzny AD. Improving clinical research and cancer care delivery in community settings: evaluating the NCI community cancer centers program. Implementation science : IS. 2009;4:63. - PMC - PubMed
    1. NCI Community Cancer Centers Program. [ http://ncccp.cancer.gov]

Publication types

LinkOut - more resources